Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Pregatis-N Tablet

Prescription Icon
Prescription Required

Marketer

Atlantis Formulations Pvt Ltd

Salt Composition

Pregabalin (75mg) + Nortriptyline (10mg)

Overview Pregatis-N Tablet

Neuropathic pain relief is provided by the combined ingredients in Pregatis-N tablets. This medication reduces pain sensations by interrupting the transmission of pain signals to the brain. Oral administration of Pregatis-N is recommended, with or without food, ideally before sleep. Consistent daily timing ensures stable blood levels. Always adhere to your physician's prescribed dosage and duration, as this medication has addictive potential. If a dose is missed, take it immediately upon recollection. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation requires prior consultation with your doctor. Common side effects include constipation, urination difficulties, weight increase, fatigue, and dry mouth. Dizziness and drowsiness may also occur; avoid driving or mentally demanding tasks until the effects are known. Weight gain may be a side effect; mitigate this through regular exercise and a balanced diet. Report any unusual mood or behavioral changes, new or worsening depression, or suicidal thoughts to your doctor immediately. Prior to starting treatment, disclose any existing kidney or liver conditions, and provide a complete list of all other medications being taken, as interactions may reduce efficacy or alter the drug's effects. Inform your doctor if you are pregnant, planning pregnancy, or breastfeeding.

Uses of Pregatis-N Tablet

Managing neuropathic pain

Major Benefits of Pregatis-N Tablet:

Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the Pregatis-N Tablet whole; avoid chewing, crushing, or breaking it. This medication can be taken with or without food, though consistent timing is recommended.

Common Side effects of Pregatis-N Tablet:

  • Dryness in mouth
  • Increased heart rate
  • Sleepiness
  • Dizziness
  • Tiredness
  • Weight gain
  • Blurred vision
  • Orthostatic hypotension (sudden lowering of blood pressure on standing)
  • Uncoordinated body movements
  • Increased appetite
  • Increased libido
  • Paresthesia (tingling or pricking sensation)
  • Vertigo
  • Vomiting
  • Nausea
  • Erectile dysfunction
  • Joint pain
  • Constipation
  • Difficulty in urination

How to use Pregatis-N Tablet:

Administer this medication according to your physician's prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing. Pregatis-N Tablets can be consumed with or without food, although consistent timing is recommended.

How Pregatis-N Tablet works:

Pregatis-N tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain transmission by modulating nerve cell calcium channels. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thus inhibiting pain signal propagation within the brain. This combined action provides effective relief from nerve damage-related pain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Concurrent use of Pregatis-N tablets and alcohol may lead to increased sleepiness.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Pregatis-N Tablets during pregnancy may pose risks. While human research is scant, animal studies indicate potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Always seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

The use of Pregatis-N Tablets while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.

DrivingDrivingUNSAFE

Driving ability may be impaired by Pregatis-N Tablet side effects, due to potential drowsiness induced by the medication.

KidneyKidneyCAUTION

Patients with kidney impairment should use Pregatis-N Tablets cautiously, potentially requiring dosage modification. A physician's consultation is advised.

LiverLiverSAFE IF PRESCRIBED

The use of Pregatis-N Tablets in individuals with liver conditions is likely safe. Existing evidence indicates dose modification may not be necessary; however, physician consultation is recommended.

What if you forget to take Pregatis-N Tablet :

Should you forget a Pregatis-N Tablet dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Pregatis-N Tablet

LabelValue
Potential for Dependence None.
Type of Treatment Nervous system.

FAQs on Pregatis-N Tablet

Pregabalin and Nortriptyline, combined as Pregatis-N Tablet, are effective in managing neuropathic pain. The medication works by modulating brain activity, thereby soothing the effects of damaged or overly stimulated nerves and reducing pain perception.
Discontinuing Pregatis-N Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including, but not limited to, anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Pregatis-N Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portion sizes. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, opt for fruits, vegetables, and low-calorie choices instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may preclude weight increase.
Pregatis-N Tablets can induce drowsiness or sudden sleep onset during routine activities. These episodes may occur without prior warning signs like drowsiness. Refrain from driving, operating equipment, working at heights, or engaging in hazardous tasks initially, until the drug's effects are understood. Report any such incidents to your physician.
Pregatis-N Tablet may impact sexual function in both genders. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to achieve orgasm). Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if such issues arise, but do not discontinue Pregatis-N Tablet without medical advice.
Rarely, Pregatis-N Tablet may cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, atypical mood or behavior (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or signs of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Pregatis-N Tablet within two weeks, though complete therapeutic effects typically manifest after two to three months. In some cases, a longer duration may be required.
Missed a scheduled Pregatis-N Tablet? If your next dose is nearly due, omit the missed dose and continue with your regular schedule. Otherwise, take the missed dose immediately and resume your usual medication routine. Avoid doubling up on doses to compensate, as this could lead to adverse reactions from an overdose. For any uncertainty, seek your physician's guidance on handling such occurrences.
If this occurs, promptly contact your physician or proceed directly to the nearest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate medical intervention may be necessary. Overdose symptoms can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Exceeding the prescribed dosage won't necessarily improve results; instead, it could heighten the risk of severe adverse reactions and harmful effects. If your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Pregatis-N Tablets can affect cognitive function and response times. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Pregatis-N Tablet use, as it may potentiate its effects. Grapefruit and its juice may interact adversely with this medication. Minimize sun exposure and avoid tanning beds; Pregatis-N Tablets increase sun sensitivity. Protective clothing and sunscreen are recommended during daytime outdoor activities.
Regular check-ups with your physician may be necessary following commencement of Pregatis-N Tablet therapy. Consult your doctor immediately if your symptoms persist despite taking the prescribed dose of Pregatis-N Tablets, or if you encounter adverse effects impacting your daily life.
Retain medication within its original packaging until administration. Store in a cool, dry location. Keep out of the reach and view of children. Dispose of any surplus medication using a designated safe method to prevent accidental ingestion by children, pets, or others.
The combination drug Pregatis-N Tablet, containing pregabalin and nortriptyline, offers relief from nerve pain (neuropathic pain). Its mechanism involves central nervous system modulation, reducing pain signals originating from damaged or hyperactive nerves. This action diminishes the perception of pain.
Discontinuing Pregatis-N Tablet prematurely, even with pain relief, is inadvisable. Adhere to your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including, but not limited to, anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Pregatis-N Tablets may stimulate appetite, potentially leading to increased food consumption and weight gain. Weight maintenance is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portion sizes. Limit high-calorie foods like sugary drinks, fried foods, potato chips, pastries, cookies, and candies. Between meals, opt for fruits, vegetables, and low-calorie snacks instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may prevent weight increase.
Pregatis-N Tablets can cause drowsiness and may lead to sudden sleep onset during routine tasks. This sleepiness may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until you assess the medication's effects. Report any such incidents to your physician.
Pregatis-N Tablet may impact sexual function in both genders. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and painful intercourse may also occur. Consult your physician if these side effects arise; however, do not discontinue Pregatis-N Tablet without medical advice.
Pregatis-N Tablet rarely produces severe adverse reactions. Seek immediate medical advice should you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or sluggish reflexes, atypical mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, visual impairment, or indications of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While infrequent, these side effects warrant prompt medical intervention.
Patients may experience initial improvements with Pregatis-N Tablet within two weeks, though complete therapeutic effects typically manifest within two to three months. For some individuals, achieving full benefit may require a longer treatment duration.
Should you miss a scheduled dose of Pregatis-N Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular schedule. If your next dose is not soon, take the medication immediately upon remembering, then resume your usual dosing pattern. Avoid doubling up on doses to compensate for a missed one, as this could lead to heightened adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the absence of symptoms. Urgent care may be necessary. Overdose indicators can manifest as lethargy, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; in fact, it could significantly raise your risk of adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for a reassessment.
Pregatis-N Tablets can affect cognitive function and reflexes. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment with Pregatis-N Tablets, as it may potentiate the drug's effects. Grapefruit and its juice may interact adversely with this medication, potentially leading to undesirable consequences. Minimize sun exposure and the use of tanning beds. Pregatis-N Tablets increase susceptibility to sunburn; protective clothing and sunscreen are recommended during daytime outdoor activities.
Regular check-ups with your physician may be necessary following the commencement of Pregatis-N Tablet therapy. Consult your doctor immediately if your symptoms fail to improve with the prescribed dosage of Pregatis-N Tablets, or if you experience persistent adverse effects impacting your daily life.
Retain the tablets in their original packaging until administration. Maintain storage in a cool, dry environment. Seclusion from children's access is imperative. Proper disposal of any remaining medication is necessary to prevent accidental ingestion by children, pets, or others.
Pregabalin and Nortriptyline, combined as Pregatis-N Tablet, provide relief from neuropathic pain. The medication works by modulating the activity of damaged or overly sensitive nerves within the central nervous system, thus reducing pain perception.
Discontinuing Pregatis-N Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Pregatis-N Tablets may increase appetite, potentially leading to weight gain. Weight management is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging portion sizes. Restrict high-calorie foods like sugary drinks, fried foods, processed snacks, and sweets. Between meals, opt for fruits, vegetables, and low-calorie alternatives instead of unhealthy snacks. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may mitigate weight increase.
Pregatis-N Tablets can cause drowsiness or sudden sleep onset during routine tasks. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities, especially initially, until you understand the medication's effects on you. Report any such incidents to your physician.
Taking Pregatis-N Tablets may impact sexual function in both males and females. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if these issues arise, but do not discontinue Pregatis-N Tablets without medical advice.
Rarely, Pregatis-N Tablet can cause serious adverse reactions. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual mood or behavioral shifts (including agitation, anxiety, or elation), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements (nystagmus), visual impairment, or signs of recurrent infection (e.g., fever, rigors, pharyngitis, oral ulcers). While infrequent, these reactions warrant prompt medical intervention.
Patients may notice some improvement from Pregatis-N Tablet within two weeks, but complete therapeutic effects usually become apparent after two to three months. For some individuals, a longer treatment duration may be necessary.
Should you miss a dose of Pregatis-N Tablet, and your next dose is nearly due, omit the missed dose and continue with your regular schedule. If your next dose is not imminent, take the missed dose immediately upon remembering, then resume your usual medication regimen. Never double the dose to compensate for a missed one; this elevates the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek advice from your physician.
If this occurs, promptly contact your physician or proceed to the nearest emergency room. Seek medical assistance regardless of the absence of symptoms. Urgent care may be necessary. Overdose symptoms can manifest as sleepiness, fatigue, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve results; it could actually heighten the risk of severe adverse reactions and harmful effects. If your symptoms worsen despite following the recommended dosage, seek medical advice for a reassessment.
Pregatis-N Tablets can affect cognitive function and response times. Exercise caution when operating machinery or engaging in activities demanding alertness. Alcohol consumption should be avoided during Pregatis-N Tablet use, as it may potentiate the drug's effects, posing a risk. Grapefruit and its juice may interact adversely with this medication, potentially leading to undesirable consequences. Minimize sun exposure and the use of tanning beds. This medication increases susceptibility to sunburn; protective clothing and sunscreen are recommended during daylight hours.
Routine checkups with your physician may be necessary following the commencement of Pregatis-N Tablet treatment. Consult your doctor immediately if your symptoms fail to improve with the prescribed dosage or if adverse effects interfere with your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry location. Keep the medication secure and inaccessible to children. Proper disposal methods for unused medicine are crucial to prevent accidental ingestion by children, pets, or others.
Pregatis-N Tablet
127
MRP 155
18% off